XML 75 R66.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Reporting - Additional Information (Detail)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
Segment
Jun. 30, 2021
USD ($)
Dec. 31, 2021
Number of operating segments | Segment     1    
Accounts receivable, percentage by customer 100.00% 100.00% 100.00% 100.00%  
Revenue $ 207,633,000 $ 162,960,000 $ 414,033,000 $ 305,797,000  
Sales Revenue          
Revenue $ 0 $ 0 $ 0 $ 0  
Customer Concentration Risk | Sales Revenue | Minimum [Member]          
Accounts receivable, percentage by customer 10.00% 10.00% 10.00% 10.00%  
Customer Concentration Risk | Accounts Receivable [Member] | Pfizer [Member]          
Accounts receivable, percentage by customer         14.00%
Customer Concentration Risk | Accounts Receivable [Member] | Customer Number One [Member]          
Accounts receivable, percentage by customer     10.00%    
Customer Concentration Risk | Total Trade Accounts Receivable Royalties And Other Receivables | Pfizer [Member]          
Accounts receivable, percentage by customer         10.00%